2 Responses to “Sedating HIV-Infected Endoscopy Patients”
M. Brian Fennerty, MD
Founding Editor
NEJM Journal Watch Gastroenterology
Learn more about Gut Check on Gastroenterology.
From NEJM: Recently in Gastroenterology- The Growing Success of Medicare Drug-Price Negotiation February 26, 2026Medicare will achieve greater savings on the 15 drugs in its second round of price negotiations than it did in the first round. Despite new challenges, the effort should continue to pay growing dividends.
- Group B Streptococcal Disease February 26, 2026Group B streptococcal infection mostly affects newborns, infants, pregnant persons, and older adults. Perinatal prevention is successful but contributes to antibiotic exposure. Multivalent glycoconjugate vaccines are in development.
- Hepatic Angiosarcoma February 12, 2026A 60-year-old man presented with a 15-day history of generalized weakness and right upper abdominal pain. Imaging studies revealed diffuse disruption of the hepatic architecture by hyperechoic nodules and areas of necrosis and hemorrhage.
- CORE Principles in the Management of Severe Hypertriglyceridemia January 29, 2026Management of hypertriglyceridemia for reducing the risk of serious clinical complications, including hypertriglyceridemia-induced acute pancreatitis, has historically been formidable and frustrating for clinicians and patients. Challenges are related to variable success in adherence to the lifestyle modifications that are required to reduce triglyceride levels, the predominantly polygenic and multifactorial determinants...
- Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk January 29, 2026In two phase 3 trials involving patients with severe hypertriglyceridemia, olezarsen led to a significantly greater reduction in the triglyceride level and in acute pancreatitis events than placebo.
- The Growing Success of Medicare Drug-Price Negotiation February 26, 2026
Brian, thanks for getting this issue out there to your GI colleagues. We have a meeting with the group in charge of policy on “conscious sedation,” and this specific question will be discussed — hope to get it resolved.
Just for the record, our HIV patients now have a projected life expectancy estimated to be decades — cancer screening recommendations that apply to HIV negative patients apply equally to them. Furthermore, the vast majority of HIV patients on antiviral therapy are receiving either efavirenz or ritonavir, so this issue of sedation for colonoscopies is a highly relevant question.
Propofol